poisar

Stocks · News reference

8-K filing — Neuphoria Therapeutics Inc. (NEUP)

Jul 23, 2026, 10:37 PMSEC EDGAR

Filed: 2026-07-24 AccNo: 0001213900-26-081052 Size: 18 MB Item 1.01: Entry into a Material Definitive Agreement Item 5.01: Changes in Control of Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

NEUP
Source
edgar
Observed
Jul 23, 2026, 10:37 PM
Checked
Jul 23, 2026, 10:37 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jul 30, 2026, 3:46 PMJuan Monteverde, Monteverde & Associates Pc

    The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX

    Monteverde & Associates PC is investigating four major M&A transactions on behalf of shareholders: Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings plc, Safety Insurance Group's sale to a Mapfre affiliate, and RE/MAX Holdings' sale to The Real Brokerage Inc. The firm encourages shareholders to contact them regarding potential concerns with these deals.

    Read original at globenewswire-inc
    NRIMNEUPSAFTRMAX